title: Interferon in the treatment of base of the skull hemangioendothelioma.
authors.affiliation: Department of Oncology, Hadassah University Hospital, Jerusalem, Israel.
authors.forename: A I
authors.initials: AI
authors.lastname: Freeman
authors.forename: A
authors.initials: A
authors.lastname: Lossos
authors.forename: J M
authors.initials: JM
authors.lastname: Gomori
authors.forename: A
authors.initials: A
authors.lastname: Schwartz
authors.forename: J
authors.initials: J
authors.lastname: Elidan
authors.forename: T
authors.initials: T
authors.lastname: Siegal
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D006390:Hemangioendothelioma / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D008297:Male; D011994:Recombinant Proteins; D019292:Skull Base Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins